MARLBOROUGH, Mass., April 3, 2018 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced the acquisition of Securus Medical Group, Inc., a privately-held company that has developed a thermal monitoring system for the continuous measurement of esophageal temperature. Boston Scientific has been an investor in Securus since 2016, and the […]
Other News
FDA Approves GORE® CARDIOFORM Septal Occluder for PFO Closure to Prevent Recurrent Ischemic Stroke
FLAGSTAFF, Ariz., April 3, 2018 /PRNewswire/ — Following the unprecedented Gore REDUCE Clinical Study conclusion that closure of patent foramen ovale (PFO) can prevent recurrent ischemic strokes, W. L. Gore & Associates, Inc. (Gore) has received approval from the U.S. Food and Drug Administration (FDA) for an expanded indication for its GORE® CARDIOFORM Septal Occluder. The device, already […]
CorWave is Set to Receive about $3.5 Million in Financing Through France’s Worldwide Innovation Challenge for Its NovaPulse Program, a Mini-Invasive Solution for Cardiac Support
CLICHY, France–(BUSINESS WIRE) CorWave, a French medical technology company that develops innovative implanted cardiac support devices for patients suffering from heart failure, announced today that it has been awarded almost $3.5 million in financing for its R&D program NovaPulse in the Silver Economy category. This is part of phase 2 of […]
IVC Filter Lawsuit News: C.R. Bard Ordered to Pay $3.6 Million at Conclusion of First Federal Bellwether Trial, Bernstein Liebhard LLP Reports
NEW YORK, April 2, 2018 /PRNewswire/ — C.R. Bard, Inc. has been ordered to pay $3.6 million to a Georgia woman who suffered serious complications after the company’s G2 inferior vena cava (IVC) filter fractured inside her body. The case was the first to go to trial in the U.S. District Court, District of Arizona, where more than […]
Abiomed Receives FDA Approval for Impella CP® with SmartAssist™ and Optical Sensor
DANVERS, Mass., April 02, 2018 (GLOBE NEWSWIRE) — Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced today that it has received U.S. Food and Drug Administration (FDA) Pre-Market Approval (PMA) for its Impella CP®heart pump with SmartAssistTM, utilizing an optical sensor. At the forefront […]
Symic Bio Announces 12-Month Results from the SHIELD Trial of SB-030 in Peripheral Vascular Disease
SAN FRANCISCO, April 2, 2018 /PRNewswire/ — Symic Bio, a biopharmaceutical company developing novel matrix-targeting biotherapeutics, today announced 12-month results from the Phase 1/2 SHIELD trial evaluating SB-030 in patients with peripheral vascular disease undergoing angioplasty. Under an extended trial protocol allowing assessment of secondary endpoint measurements at 12 months following intervention, patients […]
Bardy Diagnostics™ Names Ken Nelson Chief Commercial Officer
SEATTLE, April 2, 2018 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, including the Carnation Ambulatory Monitor (“CAM™”), the world’s smallest and lightest P-wave centric™ ambulatory cardiac monitor and arrhythmia detection device, announced today the appointment of Kenneth W. Nelson III as Chief Commercial Officer […]
Beacon® Tip Catheters Return to U.S. and Canadian Markets
BLOOMINGTON, Ind.–(BUSINESS WIRE)–Today, Cook Medical announced that physicians in the U.S. and Canada are once again able to order the Beacon® Tip Torcon NB® Advantage 5 Fr Catheter, used in angiographic procedures. In 2015 and 2016, Cook recalled all Beacon Tip Catheters due to an unexpected increase in complaints. “When we saw […]
Northwestern Memorial Hospital Surgeon First in Illinois to Repair Aortic Valve with Novel Ring
CHICAGO, March 29, 2018 /PRNewswire/ — A Northwestern Memorial Hospital cardiac surgeon helped pioneer the use of an U.S. Food and Drug Administration (FDA) approved aortic valve ring as part of a triple valve repair, the first of its kind in the United States. S. Chris Malaisrie, MD, has performed two successful surgeries using the […]
Marketwired: Mar 29, 2018 — Novoheart Files Patent Application on Disease Modeling Based on Landmark Research Conducted During Second Contract with Global Pharma Partner
VANCOUVER, BRITISH COLUMBIA — (Marketwired) — Mar 29, 2018 — Novoheart (“Novoheart” or the “Company”) (TSX VENTURE: NVH)(FRANKFURT: 3NH) is pleased to announce that it has filed a patent application on the use of its proprietary MyHeart™ Platform of human bioengineered heart tissues to create disease models for neurological diseases in which […]



